Today the FDA approved Vectibix for treatment of metastatic colorectal cancer. Vectibix is the brand name for panitumumab and works against EGFR, the same growth factor that Erbitux works against.
To read the press release from Amgen:
http://www.amgen.com/media/media_pr_det ... eID=909842
Hannah